欧洲白血病网研究:隐匿性真性红细胞增多症骨髓特征的可重复性及与原发性血小板增多症的鉴别
六名血液病理学家盲法独立评估98份骨髓标本,包括48例按原血红蛋白阈值定义的隐匿性真性红细胞增多症(mPV)、31例按2016年WHO标准诊断的显性PV和19例对照。评估者间总体一致率92.6%,kappa 0.812,几乎所有mPV病例根据骨髓形态被正确分类为PV,且mPV与显性PV的骨髓形态无显著差异。
要点
- 六名血液病理学家对98份骨髓标本的评估总体一致率为92.6%,kappa值为0.812。
- 几乎所有mPV病例根据骨髓形态被正确分类为PV。
- mPV与显性PV在骨髓形态上无显著差异。
核心结论
- 六名血液病理学家对组织学切片的中心盲法复核显示,PV具有高度可重复的特异性组织学模式,并证实mPV与显性PV在骨髓形态上无显著差异。
研究设计与样本
- 国际小组由六名血液病理学家组成,独立盲法评估98份骨髓标本,不知晓临床数据。
- 标本包括48例按原发表的血红蛋白阈值(男性16.0-18.4 g/dL,女性15.0-16.4 g/dL)定义的mPV、31例按2016年WHO更新标准诊断的显性PV和19例对照。
- 对照组包括JAK2突变型ET、原发性骨髓纤维化、骨髓增生异常综合征及各种反应性病变。
主要发现
- 评估者间总体一致率为92.6%,kappa值为0.812。
- 几乎所有mPV病例根据其骨髓形态被正确分类为PV。
- 在区分mPV与ET方面,评估者间一致性尤其高。
关键数值与推荐
- mPV定义采用原发表的血红蛋白阈值:男性16.0-18.4 g/dL,女性15.0-16.4 g/dL。
- 显性PV诊断采用2016年WHO更新标准。
- 评估者间总体一致率92.6%,kappa 0.812。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of the study was to assess consensus and interobserver agreement among an international panel of six hematopathologists regarding characterization and reproducibility of bone marrow (BM) histologic features used to diagnose early stage myeloproliferative neoplasms, in particular differentiation of so-called masked/prodromal polycythemia vera (mPV) from JAK2-mutated essential thrombocythemia (ET). The six members of the hematopathology panel evaluated 98 BM specimens independently and in a blinded fashion without knowledge of clinical data. The specimens included 48 cases of mPV according to the originally published hemoglobin threshold values for this entity (male: 16.0-18.4 g/dL, female: 15.0-16.4 g/dL), 31 cases with overt PV according to the updated 2016 WHO criteria, and 19 control cases. The latter group included cases of JAK2-mutated ET, primary myelofibrosis, myelodysplastic syndrome, and various reactive conditions. Inter-rater agreement between the panelists was very high (overall agreement 92.6%, kappa 0.812), particularly with respect to separating mPV from ET. Virtually all cases of mPV were correctly classified as PV according to their BM morphology. In conclusion, a central blinded review of histology slides by six hematopathologists demonstrated that highly reproducible specific histological pattern characterize PV and confirmed the notion that there are no significant differences between mPV and overt PV in relation to BM morphology.
引用
- Kvasnicka HM, Orazi A, Thiele J, et al. European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia. Am J Hematol. 2017. PMID: 28685840. doi:10.1002/ajh.24837
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。